Su, Y.; Qi, M.; Vasini, S.; Reid, M.E.; Rittenhouse-Olson, K.; Dy, G.K.; Wu, Y.
Exosomal Thomsen–Friedenreich Glycoantigen as a Sensitive and Specific Biomarker for Colon, Ovarian and Prostate Cancer Diagnosis. Cancers 2025, 17, 3729.
https://doi.org/10.3390/cancers17233729
AMA Style
Su Y, Qi M, Vasini S, Reid ME, Rittenhouse-Olson K, Dy GK, Wu Y.
Exosomal Thomsen–Friedenreich Glycoantigen as a Sensitive and Specific Biomarker for Colon, Ovarian and Prostate Cancer Diagnosis. Cancers. 2025; 17(23):3729.
https://doi.org/10.3390/cancers17233729
Chicago/Turabian Style
Su, Yafei, Man Qi, Shoaib Vasini, Mary E. Reid, Kate Rittenhouse-Olson, Grace K. Dy, and Yun Wu.
2025. "Exosomal Thomsen–Friedenreich Glycoantigen as a Sensitive and Specific Biomarker for Colon, Ovarian and Prostate Cancer Diagnosis" Cancers 17, no. 23: 3729.
https://doi.org/10.3390/cancers17233729
APA Style
Su, Y., Qi, M., Vasini, S., Reid, M. E., Rittenhouse-Olson, K., Dy, G. K., & Wu, Y.
(2025). Exosomal Thomsen–Friedenreich Glycoantigen as a Sensitive and Specific Biomarker for Colon, Ovarian and Prostate Cancer Diagnosis. Cancers, 17(23), 3729.
https://doi.org/10.3390/cancers17233729